Abstract
We examine the interface between for‐profit and publicly funded research in pharmaceuticals. Firms access upstream basic research through investments in absorptive capacity in the form of in‐house basic research and ‘pro‐publication’ internal incentives. Some firms also maintain extensive connections to the wider scientific community, which we measure using data on coauthorship of scientific papers between pharmaceutical company scientists and publicly funded researchers. ‘Connectedness’ is significantly correlated with firms’ internal organization, as well as their performance in drug discovery. The estimated impact of ‘connectedness’ on private research productivity implies a substantial return to public investments in basic research.
Keywords
Affiliated Institutions
Related Publications
What Firms Do? Coordination, Identity, and Learning
Firms are organizations that represent social knowledge of coordination and learning. But why should their boundaries demarcate quantitative shifts in the knowledge and capabili...
Protection of minority interest and the development of security markets
While excessive regulation is an obstacle to the development of financial markets, we argue that lack of basic rules or poorly enforced regulation may explain the relative impor...
Social Structure in a Group of Scientists: A Test of the "Invisible College" Hypothesis
The existence of social organization within a research area may be inferred (a) if scientists who have published in the area have more social ties with one another than with sci...
Publication Info
- Year
- 1998
- Type
- article
- Volume
- 46
- Issue
- 2
- Pages
- 157-182
- Citations
- 1210
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1111/1467-6451.00067